Cornell researchers have confirmed that a previously identified biomarker for detecting the presence of malignant testicular ...
10h
News-Medical.Net on MSNNew trial aims to make rectal cancer more responsive to radiationCity of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National ...
The new model, DeepSeek-V3-0324, is available through the AI development platform Hugging Face as part of the company’s ...
1h
News Medical on MSNYale study unlocks potential of lupus-related antibody to target cold tumorsYale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into "cold" tumors and flip on an immune ...
Researchers at Yale Cancer Center have made a breakthrough finding that could lead to a therapies for glioblastoma and other aggressive cancers that are extremely ...
7h
The Christian Post on MSNMiracle or science?: ‘Investigating the Supernatural’ doc explores healings that defy explanationInvestigating the Supernatural Miracles, a new documentary from journalist Billy Hallowell and CBN, gives an in-depth look at ...
3h
MyStateline.com on MSNRockford doctor works with her students to find quicker ways to detect lung cancerDr. Neelu Puri is leading lung cancer research at the University of Illinois College of Medicine Rockford, promoting early ...
Mia Love, the first Black Republican woman elected to Congress, died three years after being diagnosed with glioblastoma, a ...
Burning Rock Biotech Limited’s BNR share price has dipped by 12.36%, which has investors questioning if this is right time to ...
In addition to its scientific sessions, PathAI will host H&E by the Sea, an AI-powered pathology networking event on March 25 th at 6:00 p.m. ET at the Nautilus Pier 4. The event will bring together ...
Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...
Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results